AC Immune SA (ACIU)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$3.17

Buy

$3.34

arrow-down$-0.11 (-3.33%)

Prices updated at 14 Apr 2026, 21:28 EDT

Prices minimum 15 mins delay

Prices in USD

AC Immune SA is a clinical stage biopharmaceutical company. It discovers, designs and develops novel, proprietary medicines for treatment of neurodegenerative diseases with the help of proprietary platforms.

NASDAQ

1.96%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$3.33 - $3.19
	$4.00 - $1.45
	-
	334.84m
	-
	-
	176,676
	5.89
	337,528.88
	3.25
	112.64m
	CH0329023102
	-0.70
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.